S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
Birthplace of the atomic bomb braces for its biggest mission since the top-secret Manhattan Project
Options Trading Plan–Perfect For Beginners (Ad)
MILAN FASHION PHOTOS: Naomi Campbell stuns at Dolce&Gabbana in collection highlighting lingerie
Minnesota's would-be head of cannabis regulation quits amid reports she sold illegal products
Options Trading Plan–Perfect For Beginners (Ad)
Speaker McCarthy is giving hard-right Republicans what they want. But it never seems to be enough.
At UN, African leaders say enough is enough: They must be partnered with, not sidelined
Options Trading Plan–Perfect For Beginners (Ad)
High-speed rail was touted as a game-changer in Britain. Costs are making the government think twice
Leading Egyptian opposition politician targeted with spyware, researchers find
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
Birthplace of the atomic bomb braces for its biggest mission since the top-secret Manhattan Project
Options Trading Plan–Perfect For Beginners (Ad)
MILAN FASHION PHOTOS: Naomi Campbell stuns at Dolce&Gabbana in collection highlighting lingerie
Minnesota's would-be head of cannabis regulation quits amid reports she sold illegal products
Options Trading Plan–Perfect For Beginners (Ad)
Speaker McCarthy is giving hard-right Republicans what they want. But it never seems to be enough.
At UN, African leaders say enough is enough: They must be partnered with, not sidelined
Options Trading Plan–Perfect For Beginners (Ad)
High-speed rail was touted as a game-changer in Britain. Costs are making the government think twice
Leading Egyptian opposition politician targeted with spyware, researchers find
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
Birthplace of the atomic bomb braces for its biggest mission since the top-secret Manhattan Project
Options Trading Plan–Perfect For Beginners (Ad)
MILAN FASHION PHOTOS: Naomi Campbell stuns at Dolce&Gabbana in collection highlighting lingerie
Minnesota's would-be head of cannabis regulation quits amid reports she sold illegal products
Options Trading Plan–Perfect For Beginners (Ad)
Speaker McCarthy is giving hard-right Republicans what they want. But it never seems to be enough.
At UN, African leaders say enough is enough: They must be partnered with, not sidelined
Options Trading Plan–Perfect For Beginners (Ad)
High-speed rail was touted as a game-changer in Britain. Costs are making the government think twice
Leading Egyptian opposition politician targeted with spyware, researchers find
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
Birthplace of the atomic bomb braces for its biggest mission since the top-secret Manhattan Project
Options Trading Plan–Perfect For Beginners (Ad)
MILAN FASHION PHOTOS: Naomi Campbell stuns at Dolce&Gabbana in collection highlighting lingerie
Minnesota's would-be head of cannabis regulation quits amid reports she sold illegal products
Options Trading Plan–Perfect For Beginners (Ad)
Speaker McCarthy is giving hard-right Republicans what they want. But it never seems to be enough.
At UN, African leaders say enough is enough: They must be partnered with, not sidelined
Options Trading Plan–Perfect For Beginners (Ad)
High-speed rail was touted as a game-changer in Britain. Costs are making the government think twice
Leading Egyptian opposition politician targeted with spyware, researchers find
NASDAQ:RDNT

RadNet (RDNT) Stock Forecast, Price & News

$27.61
+0.31 (+1.14%)
(As of 09/22/2023 ET)
Compare
Today's Range
$27.02
$27.81
50-Day Range
$27.30
$34.99
52-Week Range
$12.03
$35.18
Volume
323,523 shs
Average Volume
548,358 shs
Market Capitalization
$1.87 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$33.33

RadNet MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
20.7% Upside
$33.33 Price Target
Short Interest
Healthy
2.46% of Shares Sold Short
Dividend Strength
N/A
Sustainability
-0.52
Upright™ Environmental Score
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
7.89%
From $0.38 to $0.41 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.13 out of 5 stars

Medical Sector

458th out of 965 stocks

Medical Laboratories Industry

13th out of 23 stocks


RDNT stock logo

About RadNet (NASDAQ:RDNT) Stock

RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. The company operates in two segments: Imaging Centers and Artificial Intelligence. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems that distribute, display, store, and retrieve digital images; offers picture archiving communications systems and related services; and develops and deploys AI suites to enhance radiologist interpretation of breast, lung, and prostate images, as well as AI solutions for prostate cancer screening. RadNet, Inc. was founded in 1981 and is headquartered in Los Angeles, California.

RDNT Price History

RDNT Stock News Headlines

StockNews.com Upgrades RadNet (NASDAQ:RDNT) to "Hold"
Buy This Stock for AI Tidal Wave (not NVDA)
The internet boom made more millionaires than any tech  - Microsoft’s CEO says AI has even more potential. Here’s the #1 stock to buy.
Jim Cramer Says This Major Telecom Stock Is 'Horrendous'
RadNet (RDNT) Q2 Earnings and Revenues Top Estimates
A Preview Of RadNet's Earnings
[BREAKING] Pentagon to Spend Billions on "Living Missile"
Air Force Magazine calls it "transformational." The Wall Street Journal calls it one of the Pentagon's "highest priorities." National Defense Magazine reports "Eye-popping budget" for it. This small company won the first contract to build them!
Why RadNet (RDNT) Stock Is Getting Hammered
RadNet Shares Fall After Pricing Stock Offering
Raymond James Keeps Their Buy Rating on Radnet (RDNT)
RadNet earnings: here's what Wall Street expects
See More Headlines
Receive RDNT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for RadNet and its competitors with MarketBeat's FREE daily newsletter.

RDNT Company Calendar

Last Earnings
8/08/2023
Today
9/24/2023
Next Earnings (Estimated)
11/08/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Medical laboratories
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:RDNT
Employees
9,067
Year Founded
1980

Price Target and Rating

Average Stock Price Forecast
$33.33
High Stock Price Forecast
$40.00
Low Stock Price Forecast
$30.00
Forecasted Upside/Downside
+20.7%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
3 Analysts

Profitability

Net Income
$10.65 million
Pretax Margin
1.09%

Debt

Sales & Book Value

Annual Sales
$1.43 billion
Cash Flow
$3.54 per share
Book Value
$8.57 per share

Miscellaneous

Free Float
64,771,000
Market Cap
$1.87 billion
Optionable
Optionable
Beta
1.68

Social Links

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Key Executives

  • Dr. Howard G. Berger M.D. (Age 77)
    Chairman, Pres & CEO
    Comp: $5.56M
  • Mr. Mark D. Stolper (Age 52)
    Exec. VP & CFO
    Comp: $1.13M
  • Mr. Mital Patel (Age 37)
    Exec. VP of Financial Planning & Analysis and Chief Admin. Officer
    Comp: $1.15M
  • Mr. Norman R. HamesMr. Norman R. Hames (Age 67)
    Pres & COO of Western Operations
    Comp: $1.28M
  • Mr. Stephen M. Forthuber (Age 62)
    Pres & COO of Eastern Operations
    Comp: $1.3M
  • Ms. Christine Nayoma Gordon (Age 60)
    Sr. VP of Operations - Northern California & Director
    Comp: $384.38k
  • Mr. Ranjan Jayanathan (Age 67)
    Exec. VP, Chief Information Officer & GM of eRAD - Radiology Information Technology Division
  • Dr. Gregory Sorensen M.D. (Age 61)
    Exec. VP, Chief Science Officer & Director
  • Ms. Laura Foster BSRT
    MPH, J.D., Sr. VP of Compliance & Regulatory Affairs
  • Mr. David Jeffrey Katz (Age 58)
    Exec. VP, Chief Legal Officer & Corp. Sec.













RDNT Stock - Frequently Asked Questions

Should I buy or sell RadNet stock right now?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for RadNet in the last twelve months. There are currently 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" RDNT shares.
View RDNT analyst ratings
or view top-rated stocks.

What is RadNet's stock price forecast for 2023?

3 Wall Street research analysts have issued 12 month target prices for RadNet's stock. Their RDNT share price forecasts range from $30.00 to $40.00. On average, they predict the company's share price to reach $33.33 in the next year. This suggests a possible upside of 20.7% from the stock's current price.
View analysts price targets for RDNT
or view top-rated stocks among Wall Street analysts.

How have RDNT shares performed in 2023?

RadNet's stock was trading at $18.83 at the beginning of 2023. Since then, RDNT shares have increased by 46.6% and is now trading at $27.61.
View the best growth stocks for 2023 here
.

When is RadNet's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, November 8th 2023.
View our RDNT earnings forecast
.

How were RadNet's earnings last quarter?

RadNet, Inc. (NASDAQ:RDNT) posted its quarterly earnings data on Tuesday, August, 8th. The medical research company reported $0.24 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.07 by $0.17. The medical research company earned $403.70 million during the quarter, compared to analyst estimates of $389.29 million. RadNet had a negative net margin of 0.84% and a positive trailing twelve-month return on equity of 3.98%. The firm's revenue for the quarter was up 13.9% on a year-over-year basis. During the same period last year, the firm posted $0.15 earnings per share.

What guidance has RadNet issued on next quarter's earnings?

RadNet issued an update on its FY 2023 earnings guidance on Tuesday, August, 8th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $1.57 billion-$1.61 billion, compared to the consensus revenue estimate of $1.54 billion.

What is Howard G. Berger's approval rating as RadNet's CEO?

174 employees have rated RadNet Chief Executive Officer Howard G. Berger on Glassdoor.com. Howard G. Berger has an approval rating of 45% among the company's employees. This puts Howard G. Berger in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of RadNet own?

Based on aggregate information from My MarketBeat watchlists, some companies that other RadNet investors own include Advanced Micro Devices (AMD), AbbVie (ABBV), Inovio Pharmaceuticals (INO), NVIDIA (NVDA), OPKO Health (OPK), Boeing (BA), Rigel Pharmaceuticals (RIGL), UnitedHealth Group (UNH), Pfizer (PFE) and AT&T (T).

What is RadNet's stock symbol?

RadNet trades on the NASDAQ under the ticker symbol "RDNT."

Who are RadNet's major shareholders?

RadNet's stock is owned by a variety of retail and institutional investors. Top institutional investors include BlackRock Inc. (13.80%), Beck Mack & Oliver LLC (5.59%), Point72 Asset Management L.P. (3.05%), State Street Corp (2.97%), Dimensional Fund Advisors LP (2.74%) and Global Alpha Capital Management Ltd. (2.63%). Insiders that own company stock include Christine Nayoma Gordon, David L Swartz, John V Crues, Lawrence L Levitt, Lawrence L Levitt, Michael N Murdock, Norman R Hames and Ruth Louisa Villigerwilson.
View institutional ownership trends
.

How do I buy shares of RadNet?

Shares of RDNT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is RadNet's stock price today?

One share of RDNT stock can currently be purchased for approximately $27.61.

How much money does RadNet make?

RadNet (NASDAQ:RDNT) has a market capitalization of $1.87 billion and generates $1.43 billion in revenue each year. The medical research company earns $10.65 million in net income (profit) each year or ($0.25) on an earnings per share basis.

How many employees does RadNet have?

The company employs 9,067 workers across the globe.

How can I contact RadNet?

RadNet's mailing address is 1510 COTNER AVE, LOS ANGELES CA, 90025. The official website for the company is www.radnet.com. The medical research company can be reached via phone at (310) 445-2800, via email at investorrelations@radnet.com, or via fax at 310-445-2980.

This page (NASDAQ:RDNT) was last updated on 9/24/2023 by MarketBeat.com Staff

My Account -